Narrow search
Showing 1 - 2 of 2
Cover Image
Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece: A Cost-Utility Analysis
Kourlaba, Georgia; Fragoulakis, Vassilis; Maniadakis, Nikos - In: Applied Health Economics and Health Policy 10 (2012) 4, pp. 261-271
Background:Background: Current guidelines recommend treatment with antiplatelet and anticoagulant therapy for the secondary prevention of atherothrombotic events among patients with non-ST-segment elevation myocardial infarction (NSTEMI) or unstable angina (UA). The CURE (Clopidogrel in Unstable...
Persistent link: https://www.econbiz.de/10010552619
Cover Image
Clopidogrel versus Aspirin in Patients with Atherothrombosis: A CAPRIE-Based Cost-Effectiveness Model for Greece
Kourlaba, Georgia; Fragoulakis, Vassilis; Maniadakis, Nikos - In: Applied Health Economics and Health Policy 10 (2012) 5, pp. 331-342
Background:Background: Atherothrombosis represents a leading cause of morbidity and mortality worldwide. Given the prominent role of platelet aggregation in atherothrombosis, antiplatelet therapy forms the cornerstone of treatment, with proven efficacy in the secondary prevention of...
Persistent link: https://www.econbiz.de/10010567015